| Metric | Value (₹ Cr) | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue | 33.11 | 31.6% | 46.3% |
| Total Income | 33.76 | 31.2% | 45.0% |
| Expenditure | 32.35 | 32.7% | 46.2% |
| PBT | 1.42 | 43.4% | 22.6% |
| Net Profit | 1.42 | 150.8% | 22.6% |
| OPM | 2.34% | 1.63pp | 0.08pp |
| NPM | 4.19% | 3.04pp | 0.77pp |
| EPS | 0.29 | 141.7% | 20.8% |
Revenue grew a strong 46.3% YoY with core operating margin actually inching up (OPM 2.26%→2.34%), though PAT growth of 22.6% lagged as flat other income diluted net margin on a still-tiny profit base.
Aayush Wellness Q1 FY27 Revenue Up 46% to ₹33.11 Cr
13 Aug 2026 · 13 Aug, 6:11 pm
Summary
Aayush Wellness Limited announced its unaudited consolidated financial results for Q1 FY27, reporting a robust 46.3% year-over-year revenue growth to ₹33.11 crore. Profit After Tax (PAT) also saw a substantial increase, growing 22.6% YoY to ₹1.42 crore and an impressive 150.8% QoQ. Management attributed these strong results to the expansion of their product portfolio, growth in digital commerce channels, and enhanced distribution efficiency. The company remains focused on product innovation, market penetration, and operational efficiency to drive sustainable, profitable growth.
Key Highlights
- 1
Aayush Wellness Limited reported a consolidated revenue from operations of ₹33.11 crore for Q1 FY27, marking a significant 46.3% year-over-year growth from ₹22.63 crore in Q1 FY26.
- 2
Consolidated Profit After Tax (PAT) surged to ₹1.42 crore in Q1 FY27, an increase of 22.6% year-over-year from ₹1.16 crore in Q1 FY26.
- 3
Profit After Tax (PAT) demonstrated exceptional quarter-over-quarter growth, rising by 150.8% to ₹1.42 crore in Q1 FY27 from ₹0.56 crore in Q4 FY26.
- 4
Earnings Per Share (EPS) grew by 20.8% year-over-year to ₹0.29 in Q1 FY27, compared to ₹0.24 in Q1 FY26.
- 5
The company's expansion of its product portfolio, scale-up of digital commerce channels, and improved distribution efficiency were key drivers of its financial performance.
- 6
Naveenakumar Kunjaru, Managing Director, highlighted the 46.3% YoY revenue growth as evidence of underlying demand strength and the 150.8% QoQ PAT increase as a result of improved operating leverage and cost discipline.
Management Comments
Naveenakumar Kunjaru
Q1 FY27 reflects continued progress in building a scalable consumer healthcare platform. The 46.3% YoY revenue growth demonstrates underlying demand strength, while the 150.8% QoQ increase in PAT underscores improved operating leverage and cost discipline. Our focus remains on evidence-based product innovation, deeper penetration in Tier 2/3 markets, and selective international expansion.
Informational and educational content only. Not investment advice.